JG
WGS icon

Jefferies Group’s GeneDx Holdings WGS Stock Holding History

Jefferies Group’s Portfolio WGS Stock Details WGS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-28,053
Closed -$13M – 2057
2021
Q2 		$13M Buy
28,053
+757
+3% +$325K 0.08% 209
2021
Q1 		$13.4M Buy
27,296
+22,925
+524% +$11.9M 0.12% 136
2020
Q4 		$1.59M Buy
+4,371
New +$1.52M 0.01% 795

Other funds holding WGS

Blackstone Inc
Blackstone Inc New York $32.9B AUM 23.66% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
SM
SB Management Abu Dhabi, United Arab Emirates $516M AUM 40.71% 1-Year Est. Return
CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return
CM
Corvex Management New York $3.27B AUM 38.53% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Jefferies Group's WGS Position: Q3 2021 in Review

Jefferies Group sold out of GeneDx Holdings (WGS) in Q3 2021, closing a stake of 28,053 shares — an estimated $13M sold.

Jefferies Group first reported a position in WGS in Q4 2020 and held it in 3 quarters. The position peaked at $13.4M in Q1 2021. 86 funds tracked by Wall St. Rank hold WGS as of Q3 2021.

  • Jefferies Group reported no remaining GeneDx Holdings position as of Q3 2021 after selling out during the quarter.
  • Jefferies Group sold 28,053 GeneDx Holdings shares in Q3 2021, an estimated $13M.
  • Jefferies Group first reported a position in GeneDx Holdings in Q4 2020 and held it in 3 quarters.
  • Jefferies Group's GeneDx Holdings position peaked at $13.4M in Q1 2021.
  • 86 funds tracked by Wall St. Rank held GeneDx Holdings as of Q3 2021.

Based on Jefferies Group's 13F filing for Q3 2021, filed 15 Nov 2021.